Antagonistic Effects of CAPE (a Component of Propolis) on the Cytotoxicity and Genotoxicity of Irinotecan and SN38 in Human Gastrointestinal Cancer Cells In Vitro
The incidence of gastrointestinal cancers is increasing every year. Irinotecan (CPT-11), a drug used in the treatment of colorectal cancer and gastric cancer, is metabolized by carboxylesterases to an active metabolite, SN-38, which is more cytotoxic. CAPE (caffeic acid phenethyl ester) is an active...
Main Authors: | Gabriela Gajek, Beata Marciniak, Jarosław Lewkowski, Renata Kontek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/3/658 |
Similar Items
-
Irinotecan—Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview
by: Mateusz Kciuk, et al.
Published: (2020-07-01) -
Full-profile pharmacokinetics, anticancer activity and toxicity of an extended release trivalent PEGylated irinotecan prodrug
by: Shiwen Song, et al.
Published: (2023-08-01) -
The Use of Endo-Cellulase and Endo-Xylanase for the Extraction of Apple Pectins as Factors Modifying Their Anticancer Properties and Affecting Their Synergy with the Active Form of Irinotecan
by: Jerzy Maksymowicz, et al.
Published: (2022-06-01) -
Predictors of Irinotecan Toxicity and Efficacy in Treatment of Metastatic Colorectal Cancer
by: Adam Paulík, et al.
Published: (2012-01-01) -
Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy
by: Shuang Zhang, et al.
Published: (2022-05-01)